Score Overview
Explore the 2021 public Archive ranking →
Where Bio-Rad Laboratories Inc has ranked, year by year
Showing 10 years ranking history by HDB Score.
Has not reached the top 50 on HDB Score in any year we have ranked.
- BIO
1996: 33.7% · 2021: 25.5% · free through 2021 · longest runs
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-11-17 | $ 358.19 | — |
1 Year2025-11-17 | $ 304.06 | 17.80% |
5 Years2021-11-17 | $ 779.99 | -54.08% |
10 Years2016-11-17 | $ 173.76 | 106.14% |
20 Years2006-11-17 | $ 79.71 | 349.37% |
30 Years1996-11-15 | $ 14.94 | 23x |
| Period | Last Price2026-11-17 | 1 Year2025-11-17 | 5 Years2021-11-17 | 10 Years2016-11-17 | 20 Years2006-11-17 | 30 Years1996-11-15 |
|---|---|---|---|---|---|---|
| Price | $ 358.19 | $ 304.06 | $ 779.99 | $ 173.76 | $ 79.71 | $ 14.94 |
| Return | — | 17.80% | -54.08% | 106.14% | 349.37% | 23x |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in USD
| Year | |||
|---|---|---|---|
| TTM | $ 2.59B | $ 1.02B | $ 1.66B |
| 2025 | $ 2.58B | $ 759M | $ 1.54B |
| 2024 | $ 2.56B | -$ 1.84B | $ 1.66B |
| 2023 | $ 2.67B | -$ 637M | $ 1.60B |
| 2022 | $ 2.80B | -$ 3.62B | $ 1.79B |
| 2021 | $ 2.92B | $ 4.25B | $ 869M |
| 2020 | $ 2.54B | $ 3.81B | $ 991M |
| 2019 | $ 2.31B | $ 1.75B | $ 1.11B |
| 2018 | $ 2.29B | $ 360M | $ 844M |
| 2017 | $ 2.16B | $ 114M | $ 754M |
| 2016 | $ 2.06B | $ 28M | $ 839M |
| 2015 | $ 2.01B | $ 113M | $ 786M |
| 2014 | $ 2.17B | $ 88M | $ 697M |
| 2013 | $ 2.13B | $ 77M | $ 608M |
| 2012 | $ 2.06B | $ 169M | $ 921M |
| 2011 | $ 2.07B | $ 178M | $ 813M |
| 2010 | $ 1.92B | $ 185M | $ 1.02B |
| 2009 | $ 1.78B | $ 144M | $ 744M |
| 2008 | $ 1.76B | $ 89M | $ 243M |
| 2007 | $ 1.46B | $ 92M | $ 223M |
| 2006 | $ 1.27B | $ 103M | $ 488M |
| 2005 | $ 1.18B | $ 81M | $ 413M |
| 2004 | $ 1.09B | $ 68M | $ 361M |
| 2003 | $ 1.00B | $ 76M | $ 148M |
| 2002 | $ 892M | $ 67M | $ 27M |
| 2001 | $ 817M | $ 44M | $ 47M |
| 2000 | $ 725M | $ 31M | $ 13M |
| 1999 | $ 549M | $ 11M | $ 17M |
| 1998 | $ 441M | $ 24M | $ 10M |
| 1997 | $ 426M | $ 16M | $ 10M |
| 1996 | $ 418M | $ 26M | $ 9M |
| 1995 | $ 396M | $ 25M | $ 14M |
| 1994 | $ 355M | $ 15M | $ 3M |
| 1993 | $ 328M | $ 2M | $ 3M |
| 1992 | $ 330M | $ 15M | $ 2M |
| 1991 | $ 310M | $ 8M | $ 4M |
| 1990 | $ 286M | $ 10M | $ 2M |
| 1989 | $ 236M | $ 10M | $ 2M |
| 1988 | $ 198M | $ 9M | $ 4M |
| 1987 | $ 159M | $ 7M | $ 1M |
| 1986 | $ 126M | $ 6M | $ 2M |
| 1985 | $ 102M | $ 4M | $ 6M |

Bio-Rad Laboratories Inc fundamental performance
Between 2005 and 2025, revenue grew from $ 1.18B to $ 2.58B and net income grew from $ 81M to $ 759M. Revenue increased in 15 of those 20 years; net income in 12.
Across Bio-Rad Laboratories Inc's full reported history, from 1985 to 2025, revenue grew from $ 102M to $ 2.58B and net income grew from $ 4M to $ 759M. Revenue increased in 85% of the years measured; net income in 68%.
Bio-Rad Laboratories Inc currently holds a 20-year HDB Score of 6.0 out of 10. How the HDB Score is calculated.
Membership
Continue BIO’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 5,187 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
Explore other companies
AMN Healthcare Services IncAMN· revenue grew in 75% of years
Corcept Therapeutics IncorporatedCORT· revenue grew in 89% of years
Healthcare Services Group IncHCSG· revenue grew in 80% of years
McKesson CorporationMCK· revenue grew in 95% of years
Laboratory Corporation of America HoldingsLH· revenue grew in 90% of years